Single Ascending Dose Study of PRX002 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2014

Conditions
Parkinson's Disease
Interventions
DRUG

PRX002

OTHER

Placebo

Trial Locations (1)

Unknown

San Antonio

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Prothena Biosciences Limited

INDUSTRY

NCT02095171 - Single Ascending Dose Study of PRX002 in Healthy Subjects | Biotech Hunter | Biotech Hunter